Clinical Trial Update: Efficacy of Risk-Stratified Treatment in Newly Diagnosed Infant Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update from Yonsei University evaluating risk-stratified treatment for newly diagnosed infant acute lymphoblastic leukemia; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infant Acute Lymphoblastic Leukemia

Snippet

Sponsor: Yonsei University | Conditions: Leukemia, Lymphoid | Phase 2 | Status: RECRUITING